These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4079597)

  • 1. Antagonistic activity of aligeron and papaverine against different smooth muscle stimuli.
    Miyares K; Delfin M; Nikolov R; Nikolova M
    Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):473-6. PubMed ID: 4079597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the prostaglandin antagonistic activity of aligeron and piracetam.
    Nikolov R; Rakovska A; Dushkova R; Dimitrova L; Pavlidu A
    Methods Find Exp Clin Pharmacol; 1982; 4(6):387-95. PubMed ID: 6958951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of papaverine and verapamil on norepinephrine and calcium evoked contraction of vascular and non vascular smooth muscle.
    D'Agostino G; Zonta F; Dondi G; Grana E
    Pharmacol Res Commun; 1983 Nov; 15(10):937-49. PubMed ID: 6336540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the Ca2+-antagonistic activity of some Bulgarian vasodilating agents and of known Ca2+-antagonists on K+-depolarized smooth muscle from guinea-pig taenia coli.
    Mutafova-Yambolieva V; Staneva-Stoytcheva D; Nikolov R
    Acta Physiol Pharmacol Bulg; 1989; 15(2):40-6. PubMed ID: 2801147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the inhibitory effect of cinnarizine and papaverine on the noradrenaline- and calcium-evoked contraction of isolated rabbit aorta and mesenteric arteries.
    Broekaert A; Godfraind T
    Eur J Pharmacol; 1979 Jan; 53(3):281-8. PubMed ID: 759205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nitrendipine (BAY e 5009), nifedipine, verapamil, phentolamine, papaverine, and minoxidil on contractions of isolated rabbit aortic smooth muscle.
    Towart R
    J Cardiovasc Pharmacol; 1982; 4(6):895-902. PubMed ID: 6185780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
    Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-adrenoceptor-blocking properties of some trypanocidal diamidines.
    Steinmann U; Estler CJ; Dann O
    Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):207-14. PubMed ID: 2895613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of papaverine, D600, and nifedipine on the effects of noradrenaline and calcium on the isolated aorta and mesenteric artery of the rabbit.
    Schümann HJ; Görlitz BD; Wagner J
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(4):409-18. PubMed ID: 1161061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic effects of dipfluzine, flunarizine, and cinnarizine on 5-hydroxytryptamine-evoked contraction in pig basilar artery.
    Zhu YH; Wang YL; Yang XP
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):321-3. PubMed ID: 9812713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies on the effect of Aligeron on the cerebral circulation.
    Vlahov V; Nikolov R; Nikolova M
    Acta Physiol Pharmacol Bulg; 1980; 6(2):65-9. PubMed ID: 7435216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some aspects in the pharmacology of diclonium bromide (2-(3,2-dichloroanilino)quinolizinium bromide). Part I: Antispasmodic action.
    Goldenberg MM
    Arzneimittelforschung; 1976; 26(3):341-6. PubMed ID: 9098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aligeron on the resistance of the cerebral and peripheral blood vessels.
    Nikolov R; Vlahov V; Taskov M
    Acta Physiol Pharmacol Bulg; 1980; 6(3):54-9. PubMed ID: 7282382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of smooth muscle contractility by Cordemcura].
    Hagen A; Krause W; Göres E
    Pharmazie; 1986 Mar; 41(3):191-3. PubMed ID: 3714793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of antihypertensive action of diazoxide: in vitro vascular pharmacodynamics.
    Wohl AJ; Hausler LM; Roth FE
    J Pharmacol Exp Ther; 1967 Dec; 158(3):531-9. PubMed ID: 6073233
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationships between structure and vascular activity in a series of benzylisoquinolines.
    Chulia S; Ivorra MD; Martinez S; Elorriaga M; Valiente M; Noguera MA; Lugnier C; Advenier C; D'Ocon P
    Br J Pharmacol; 1997 Oct; 122(3):409-16. PubMed ID: 9351495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effects.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1517-26. PubMed ID: 7193020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.